ArticleClinical pharmacology and therapeutics2018

Evaluation of Potential Disease-Mediated Drug-Drug Interaction in Patients With Moderate-to-Severe Atopic Dermatitis Receiving Dupilumab.

John D Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.